Sometimes drug treatment is just as much art as science, and experience can make a meaningful difference around the margins.
So i'm curious why a couple of the large volume places that i've seen presentations from haven't had the negative experience that the larger dataset reveals. As jq said it's not wise to extrapolate from one or two centers, but sometimes a competent center or two can bring their experience to play and develop novel / optimal use strategies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.